Eva María López-Román

Design, Synthesis, and Evaluation of New Thiadiazole-Based Direct Inhibitors of Enoyl Acyl Carrier Protein Reductase (InhA) for the Treatment of Tuberculosis

Roman Šink, Izidor Sosič, Matej Živec et al. · Journal of Medicinal Chemistry · 2014 · 78 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides

Eleni Pitta, Maciej K. Rogacki, Olga A. Balabon et al. · Journal of Medicinal Chemistry · 2016 · 52 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Pulmonary Mycobacterium bovis BCG Vaccination Confers Dose-Dependent Superior Protection Compared to That of Subcutaneous Vaccination

Nacho Aguiló, Ana Maria Toledo, Eva María López-Román et al. · Clinical and Vaccine Immunology · 2014 · 51 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery

María José Rebollo-López, Joël Lelièvre, Daniel Álvarez-Gómez et al. · PLoS ONE · 2015 · 45 citations · Full text

Pharmacy, Bioinformatics, Medicinal Chemistry +17

Identification and Profiling of Hydantoins—A Novel Class of Potent Antimycobacterial DprE1 Inhibitors

Maciej K. Rogacki, Eleni Pitta, Olga A. Balabon et al. · Journal of Medicinal Chemistry · 2018 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15